Drugs / Calciumfolinat
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT03421288 Background | Sep 2018 → May 2027 expected | gastric cancer, gastroesophageal junction adenocarcinoma | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT02661971 Background | Jun 2016 → Dec 2021 | gastric cancer, gastroesophageal cancer | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Completed | Missed primary |
| Phase 3 | NCT00396487 Background | Nov 2006 → Feb 2008 | colorectal cancer | Vejle Hospital | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calciumfolinat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00396487 ↗ |
| Route | Intravenous | “Leucovorin 200 mg/m² in 250 ml NaCl 0.9%, iv over 30 min” NCT02661971 ↗ |